obi 999

OBI-999, a novel antibody-drug conjugate, is derived from a conjugation of a GH-specific mAb with a monomethyl auristatin E (MMAE) payload through a site-specific ThioBridge and a cleavable linker. yamada lv 999 OBI-999 high homogeneity with a drug-to-antibody ratio of 4 (95%) was achieved using ThioBridge